Trial Profile
An open-label, randomised, multicentre, phase IIIb/IV, parallel group study to compare the efficacy and safety of rosuvastatin and atorvastatin in subjects with type IIa and IIb hypercholesterolaemia (DISCOVERY)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jan 2010
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II
- Focus Therapeutic Use
- Acronyms DISCOVERY; DISCOVERY Asia
- Sponsors AstraZeneca
- 06 Feb 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 23 Nov 2005 New trial record.